FE Form 144 lists dividend reinvestments and 6,241-share vesting

FE furnished a Form 144 reporting proposed dispositions of Common Stock via a brokerage arrangement.

Rhea-AI Filing Summary

FE furnished a Form 144 reporting proposed dispositions of Common Stock via a brokerage arrangement. The filing lists repeated Dividend Reinvestment entries across periodic dates from 06/01/2017 through 09/01/2025 and a Restricted Stock Vesting entry of 6,241 shares dated 09/01/2023. The broker named is Fidelity Brokerage Services LLC with an entry showing 7,945 (label in the excerpt). The filing itemizes issuance/receipt events rather than a single aggregated offering amount.

Insights

Securities Attorney

Form 144 lists periodic dividend reinvestment and a large restricted stock vesting entry.

The excerpt enumerates numerous Dividend Reinvestment transactions dated between 06/01/2017 and 09/01/2025 and a distinct Restricted Stock Vesting line of 6,241 shares on 09/01/2023. A broker is identified: Fidelity Brokerage Services LLC.

As a filing of proposed dispositions, this is procedural; the excerpt does not state an aggregate registered resale amount, proceeds treatment, or closing mechanics. Subsequent filings or the complete Form 144 would show sales timing and cash‑flow recipients.

FAQ

What types of share dispositions does FE's Form 144 list?

The filing lists repeated Dividend Reinvestment entries and a Restricted Stock Vesting entry of 6,241 shares dated 09/01/2023, showing types of issuer-originated share issuances.

Which broker is named in the FE Form 144 excerpt?

The broker listed is Fidelity Brokerage Services LLC, with an entry referencing 7,945 in the excerpt. The broker appears as the intermediary for the reported securities activity.

Does the excerpt state a single aggregate number of shares being sold for FE?

No single aggregate offering amount is stated in the provided excerpt; it itemizes periodic dividend reinvestment entries across dates from 06/01/2017 to 09/01/2025 and the 6,241-share vesting entry.

What date appears on the Form 144 excerpt for FE?

An entry date shown in the excerpt is 03/11/2026, alongside the broker and NYSE listing; other transaction dates range between 06/01/2017 and 09/01/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 03:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001102786
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	FIRSTENERGY CORP
SEC File Number	333-21011
Address of Issuer	341 WHITE POND DRIVE AKRON OHIO 44320
Phone	330-761-7837
Name of Person for Whose Account the Securities are To Be Sold	ONEIL JAMES F
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7945	402041.81	577932879	03/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2017	Dividend Reinvestment	Issuer			25	06/01/2017	Cash
Common	09/01/2017	Dividend Reinvestment	Issuer			34	09/01/2017	Cash
Common	12/01/2017	Dividend Reinvestment	Issuer			44	12/01/2017	Cash
Common	03/01/2018	Dividend Reinvestment	Issuer			47	03/01/2018	Cash
Common	06/01/2018	Dividend Reinvestment	Issuer			45	06/01/2018	Cash
Common	09/01/2018	Dividend Reinvestment	Issuer			41	09/01/2018	Cash
Common	12/01/2018	Dividend Reinvestment	Issuer			42	12/01/2018	Cash
Common	03/01/2019	Dividend Reinvestment	Issuer			41	03/01/2019	Cash
Common	06/01/2019	Dividend Reinvestment	Issuer			41	06/01/2019	Cash
Common	09/01/2019	Dividend Reinvestment	Issuer			37	09/01/2019	Cash
Common	12/01/2019	Dividend Reinvestment	Issuer			36	12/01/2019	Cash
Common	03/01/2020	Dividend Reinvestment	Issuer			40	03/01/2020	Cash
Common	06/01/2020	Dividend Reinvestment	Issuer			42	06/01/2020	Cash
Common	09/01/2020	Dividend Reinvestment	Issuer			64	09/01/2020	Cash
Common	12/01/2020	Dividend Reinvestment	Issuer			69	12/01/2020	Cash
Common	03/01/2021	Dividend Reinvestment	Issuer			55	03/01/2021	Cash
Common	06/01/2021	Dividend Reinvestment	Issuer			50	06/01/2021	Cash
Common	09/01/2021	Dividend Reinvestment	Issuer			48	09/01/2021	Cash
Common	12/01/2021	Dividend Reinvestment	Issuer			50	12/01/2021	Cash
Common	03/01/2022	Dividend Reinvestment	Issuer			47	03/01/2022	Cash
Common	06/01/2022	Dividend Reinvestment	Issuer			46	06/01/2022	Cash
Common	09/01/2022	Dividend Reinvestment	Issuer			49	09/01/2022	Cash
Common	12/01/2022	Dividend Reinvestment	Issuer			48	12/01/2022	Cash
Common	03/01/2023	Dividend Reinvestment	Issuer			52	03/01/2023	Cash
Common	06/01/2023	Dividend Reinvestment	Issuer			55	06/01/2023	Cash
Common	09/01/2023	Dividend Reinvestment	Issuer			57	09/01/2023	Cash
Common	09/01/2023	Restricted Stock Vesting	Issuer			6241	09/01/2023	Compensation
Common	12/01/2023	Dividend Reinvestment	Issuer			59	12/01/2023	Cash
Common	03/01/2024	Dividend Reinvestment	Issuer			61	03/01/2024	Cash
Common	06/01/2024	Dividend Reinvestment	Issuer			58	06/01/2024	Cash
Common	09/01/2024	Dividend Reinvestment	Issuer			53	09/01/2024	Cash
Common	12/01/2024	Dividend Reinvestment	Issuer			55	12/01/2024	Cash
Common	03/02/2025	Dividend Reinvestment	Issuer			61	03/02/2025	Cash
Common	06/01/2025	Dividend Reinvestment	Issuer			72	06/01/2025	Cash
Common	09/01/2025	Dividend Reinvestment	Issuer			80	09/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James O'Neil III
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)